UBS O'Connor’s GE HealthCare GEHC Stock Holding History

UBS O'Connor’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-20,000	Closed	-$23.5K	–	488
2024 Q3	$23.5K	Buy	+20,000	New	+$1.68M	﹤0.01%	441

Other funds holding GEHC

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS O'Connor's GEHC Position: Q1 2024 in Review

UBS O'Connor sold out of GE HealthCare (GEHC) in Q1 2024, closing a stake of 25,203 shares — an estimated $1.95M sold.

UBS O'Connor first reported a position in GEHC in Q4 2022 and held it in 5 quarters. The position peaked at $4.38M in Q3 2023. 1,257 funds tracked by Wall St. Rank hold GEHC as of Q1 2024.

UBS O'Connor reported no remaining GE HealthCare position as of Q1 2024 after selling out during the quarter.
UBS O'Connor sold 25,203 GE HealthCare shares in Q1 2024, an estimated $1.95M.
UBS O'Connor first reported a position in GE HealthCare in Q4 2022 and held it in 5 quarters.
UBS O'Connor's GE HealthCare position peaked at $4.38M in Q3 2023.
1,257 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2024.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.